Pfizer Inc - Asset Resilience Ratio

Latest as of September 2025: 7.18%

Pfizer Inc (PFIZ34) has an Asset Resilience Ratio of 7.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Pfizer Inc (PFIZ34) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

R$14.98 Billion

≈ $2.94 Billion USD Cash + Short-term Investments

Total Assets

R$208.73 Billion

≈ $40.96 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Pfizer Inc's Asset Resilience Ratio has changed over time. See shareholders equity of Pfizer Inc for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Pfizer Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PFIZ34 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	R$1.34 Billion	0.64%
Short-term Investments	R$13.64 Billion	6.54%
Total Liquid Assets	R$14.98 Billion	7.18%

Asset Resilience Insights

Limited Liquidity: Pfizer Inc maintains only 7.18% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Pfizer Inc Industry Peers by Asset Resilience Ratio

Compare Pfizer Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSPC Pharmaceutical Group Limited F:CVG	Drug Manufacturers - General	4.64%
Aurora Optoelectronics Co Ltd SHG:600666	Drug Manufacturers - General	5.89%
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	Drug Manufacturers - General	6.44%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	10.10%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	7.18%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	14.06%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%

Annual Asset Resilience Ratio for Pfizer Inc (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Pfizer Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.60%	R$20.48 Billion ≈ $4.02 Billion	R$213.40 Billion ≈ $41.87 Billion	+3.99pp
2023-12-31	5.60%	R$12.69 Billion ≈ $2.49 Billion	R$226.50 Billion ≈ $44.44 Billion	-5.92pp
2022-12-31	11.53%	R$22.73 Billion ≈ $4.46 Billion	R$197.21 Billion ≈ $38.70 Billion	-5.59pp
2021-12-31	17.12%	R$31.07 Billion ≈ $6.10 Billion	R$181.48 Billion ≈ $35.61 Billion	+9.20pp
2020-12-31	7.92%	R$12.22 Billion ≈ $2.40 Billion	R$154.23 Billion ≈ $30.26 Billion	+2.84pp
2019-12-31	5.09%	R$8.53 Billion ≈ $1.67 Billion	R$167.59 Billion ≈ $32.88 Billion	-6.01pp
2018-12-31	11.10%	R$17.69 Billion ≈ $3.47 Billion	R$159.42 Billion ≈ $31.28 Billion	+0.24pp
2017-12-31	10.86%	R$18.65 Billion ≈ $3.66 Billion	R$171.80 Billion ≈ $33.71 Billion	+1.97pp
2016-12-31	8.89%	R$15.26 Billion ≈ $2.99 Billion	R$171.62 Billion ≈ $33.67 Billion	-2.85pp
2015-12-31	11.74%	R$19.65 Billion ≈ $3.86 Billion	R$167.38 Billion ≈ $32.84 Billion	-7.82pp
2014-12-31	19.56%	R$32.78 Billion ≈ $6.43 Billion	R$167.57 Billion ≈ $32.88 Billion	--

pp = percentage points

About Pfizer Inc

SA:PFIZ34 Brazil Drug Manufacturers - General

Market Cap

$147.67 Billion

R$752.56 Billion BRL

Market Cap Rank

#152 Global

#7 in Brazil

Share Price

R$33.09

Change (1 day)

-0.78%

52-Week Range

R$31.00 - R$36.70

All Time High

R$80.02